Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who have previously been diagnosed with Parkinson's disease
- People who have been taking a stable dose of levodopa for at least 3 months
- People who have been diagnosed with functional constipation using a standard medical assessment called the Rome IV criteria
Who may not be able to join:
- People diagnosed with atypical or secondary parkinsonism (certain related but different conditions affecting movement)
- People whose Parkinson's disease has progressed beyond a moderate stage, as measured by a scale called Hoehn and Yahr (confirm with trial site)
- People with severe neurological or psychiatric conditions that would make it difficult to take part in study activities
- People who have previously been diagnosed with dementia
- People with certain serious ongoing health conditions, including active cancer, chronic obstructive pulmonary disease (COPD), heart failure, or chronic kidney disease
- People with a history of cancers or inflammatory diseases of the digestive system, or who have had surgery involving the digestive tract
- People whose constipation is caused by another medical condition, such as an underactive thyroid or diabetes
- People who are currently using opioid medications
- People who have used probiotics or antibiotics in the past 8 weeks
- People who have been regularly using laxatives in the past 8 weeks
- People with severe swallowing difficulties, as assessed by a scale called the Functional Oral Intake Scale (confirm with trial site)
- People who are receiving nutrition through a tube or directly into a vein
- People who have been receiving professional nutritional care or monitoring in the past 3 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Maira Rozenfeld Olchik, PhD, Federal University of Rio Grande do Sul
Phone: +55 (51) 33083020
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in weekly bowel movement frequency
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.